United States Biotechnology & Medical Research

Unicycive Therapeutics Inc (UNCY)

Track

Track

Unicycive Therapeutics Inc experienced a significant divestment recently, as Vivo Opportunity Fund Holdings, L.P. proposed selling 1,789,916 shares valued at approximately $9.45 million. This transaction represents the sole activity within the last ninety days, occurring amidst a period where the stock price declined by 32.4 percent. No other insider trading transactions were recorded during this timeframe.
Ticker: UNCY Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.6
Schiller Brigitte Non-Executive Director
Transaction date
Purchase
Price
417.85
Quantity 64,854 -2.2%
Value US$4,151,896
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-01 2026-06-30 PrS Proposed sale
Vivo Opportunity Fund Holdings, L.P.

Director

Non-Executive Director
47,270
254.79
US$3,274,696 		47,270 254.79 US$3,274,696
2022-05-17 2022-05-16 B Purchase
1.6
Schiller Brigitte
Non-Executive Director
64,854 -2.2%
417.85
US$4,151,896 		64,854 -2.2% 417.85 US$4,151,896
Explore more

More insider trading research around Unicycive Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America